CRYO CELL INTERNATIONAL INC (NASDAQ:CCEL) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 13, 2026.
At publication ·
CRYO CELL INTERNATIONAL INC (NASDAQ:CCEL) · proxy filed
At a glance
CRYO CELL INTERNATIONAL INC (NASDAQ:CCEL) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 13, 2026.
The Healthcare company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
CRYO CELL INTERNATIONAL INC's stock currently trades at $4.30 with a market capitalization of $32.2M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing CRYO CELL INTERNATIONAL INC's filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for CRYO CELL INTERNATIONAL INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CCEL Stock Page
Browse all filings on our CCEL SEC filings page.
Public companies like CRYO CELL INTERNATIONAL INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Keep reading
Current market data
NASDAQ · CCEL
$5.07
Up: +$0.02 · +0.40%
Live quote updated
